Noun:

শ্বেতকণিকাধিক্যঘটিত রক্তাল্পতা,

leukemic শব্দের বাংলা অর্থ এর উদাহরণ:

চিকিৎসা-বিজ্ঞানে প্রবাহ কোষ-গণনার অপরিসীম অবীদান রয়েছে;তার মধ্যে অন্যতম-শ্বেতকণিকাধিক্যঘটিত রক্তাল্পতা নির্ধারন ।

leukemic's Usage Examples:

Transient myeloid leukemia is a pre-leukemic condition.

of acute myeloid leukemia; in other words, it is a solid collection of leukemic cells occurring outside of the bone marrow.

blood cells with leukemic cells.

A lack of normal white blood cell production makes people more susceptible to infections; while the leukemic cells themselves.

the expression of ICSBP in BCR-ABL transformed cells to generate an anti-leukemic immune protection via experimentation.

The disease was formally named leukemic reticuloendotheliosis and its characterization significantly advanced by.

In AML-M5 >80% of the leukemic cells are of monocytic lineage.

Several characteristic genetic changes lead to the creation of a leukemic lymphoblast.

replacement by leukemic cells.

By choosing appropriate antibodies, the differentiation of leukemic cells can be accurately determined.

nonspecific skin lesions that occur with leukemia which are not related to leukemic cell infiltration.

Sclareol is also able to kill human leukemic cells and colon cancer cells by apoptosis.

Cutaneous infiltration of leukemic cells may also have this appearance.

Cordycepin has displayed cytotoxicity against some leukemic cell lines in vitro, and at least one clinical trial of cordycepin as a.

significantly reduced CRS and neurotoxicity in mice, while preserving anti-leukemic efficacy.

the predominant mechanism through which imatinib eliminates leukemic cells, that leukemic animals could be cured using imatinib, and that resistance to.

are skin lesions that occur with leukemia, but which are not related to leukemic cell infiltration.

AI-10-49 is a small molecule inhibitor of leukemic oncoprotein CBFβ-SMHHC developed by the laboratory of John Bushweller (University of Virginia) with.

nervous system and with establishing and maintaining cancer-like features in leukemic cells.

shown to be different in different types of cells, including normal and leukemic lymphocytes and are often targets for pharmacological inhibition due to.

among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis), B-cell chronic lymphocytic leukemia and Relapsing-remitting.